Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design.
Bonaca MP, George RT, Morrow DA, Bergmark BA, Park JG, Abuhatzira L, Vavere AL, Karathanasis SK, Jin C, She D, Hirshberg B, Hsia J, Sabatine MS.
Bonaca MP, et al. Among authors: sabatine ms.
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):243-252. doi: 10.1093/ehjcvp/pvab001.
Eur Heart J Cardiovasc Pharmacother. 2022.
PMID: 33493256
Clinical Trial.